The store will not work correctly when cookies are disabled.
5-Bromo-N-(4-chlorophenyl)-4-(2-fluoro-4-nitrophenoxy)pyrimidin-2-amine
ID: ALA4759627
PubChem CID: 162657789
Max Phase: Preclinical
Molecular Formula: C16H9BrClFN4O3
Molecular Weight: 439.63
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(Oc2nc(Nc3ccc(Cl)cc3)ncc2Br)c(F)c1
Standard InChI: InChI=1S/C16H9BrClFN4O3/c17-12-8-20-16(21-10-3-1-9(18)2-4-10)22-15(12)26-14-6-5-11(23(24)25)7-13(14)19/h1-8H,(H,20,21,22)
Standard InChI Key: LDLWNDJZEXLGGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
0.9897 -8.6947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9885 -9.5217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7029 -9.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7011 -8.2823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4160 -8.6911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4148 -9.5237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1313 -9.9387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1337 -8.2736 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
3.8547 -8.6932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8535 -9.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5691 -9.9351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2865 -9.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2838 -8.6898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5675 -8.2799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0011 -9.9326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7146 -9.5193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4278 -9.9352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1407 -9.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1400 -8.6972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4203 -8.2862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7103 -8.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8529 -8.2831 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.7026 -10.7587 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.2788 -8.2805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4393 -8.6930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2786 -7.4561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
3 23 1 0
24 25 2 0
24 26 1 0
1 24 1 0
M CHG 2 24 1 26 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 439.63 | Molecular Weight (Monoisotopic): 437.9531 | AlogP: 5.48 | #Rotatable Bonds: 5 |
Polar Surface Area: 90.18 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.62 | CX Basic pKa: 1.44 | CX LogP: 5.72 | CX LogD: 5.72 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.42 | Np Likeness Score: -1.92 |
References
1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380] [10.1016/j.ejmech.2020.112782] |